📞  +353 1 6643768
📧  info@medaval.ie
Huawei Watch D
Device Name:
Watch D

Brand: Huawei Technologies Co. Ltd., Bantian Huawei Base, Longgang District, Shenzhen, Guangdong 518129, CHINA.

Other: Huawei Device Co. Ltd., 2 Xincheng Road, Songshan Lake Zone, Dongguan, Guangdong 523808, CHINA.

Measuring functions:
Blood pressure
Primary Client Use:
Intended for self-measurement and home use
Measurement Site:
Measurement Occurrence:
Single measurements only
Available Currently
The Huawei Watch D is an automatic blood pressure monitor. Its blood pressure measurement technology has been proven to be accurate, with a 3-star Medaval rating. Blood pressure measurements are taken from the wrist. It is intended for self-measurement and home use.
The technology used in the Huawei Watch D, to measure blood pressure, is among the best rated for accuracy by Medaval Ltd. It has passed in three clinical validation studies, between general and specific populations, according to recognised standard protocols, as published in peer-reviewed publications.
Accuracy AssessmentRecommendationBasis
BP Medaval ★★★ Recommendation Recent clinical validation; recent protocol; multiple clinical validations
BP Stride BP Self-measurement for adults Published evidence
Validation Publications:

Zhang W, Zhou YN, Zhou Y, Wang JG. Validation of the watch-type HUAWEI WATCH D oscillometric wrist blood pressure monitor in adult Chinese. Blood Press Monit. 2022 Oct 1;27(5):353-356. Epub: 2022 May 27. doi: 10.1097/MBP.0000000000000608. PMID: 35687029.

81060-2:2019 - Pass General population

Wang L, Xian H, Guo J, Li W, Wang J, Chen Q, Fu X, Li H, Chen Q, Zhang W, Chen Y. A novel blood pressure monitoring technique by smart HUAWEI WATCH: A validation study according to the ANSI/AAMI/ISO 81060-2:2018 guidelines. Front Cardiovasc Med. 2022 Oct 11;9:923655. doi: 10.3389/fcvm.2022.923655. PMID: 36304535. Available from: PMC9592900.

81060-2:2019 - Pass General population

Yi L, Lv ZH, Hu SY, Liu YQ, Yan JB, Zhang H, Li HB, Chen Q, Li YY, Jiang YF, Zhou H, Li MD, Chen RD, Li XL, Zhou SS, Chen YD. Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure. J Geriatr Cardiol. 2022 Nov 28;19(11):843-852. doi: 10.11909/j.issn.1671-5411.2022.11.004. PMID: 36561062. Available from: PMC9748271.

81060-2:2020 - Pass (n=85)

81060-2:2019 - Pass General population (Note: Stress study, as required for ABPM devices (n=35))

Lee WL, Danaee M, Abdullah A, Wong LP. Is the Blood Pressure-Enabled Smartwatch Ready to Drive Precision Medicine? Supporting Findings From a Validation Study. Cardiol Res. 2023 Dec;14(6):437-445. Epub: 2023 Dec 9. doi: 10.14740/cr1569. PMID: 38187511. Available from: PMC10769613.

81060-2:2019 (n=78) (Note: Protocol violations, including insufficient sample size and incorrect reporting of BP distribution (subjects instead of measurements), mean that this study must be considered as following a non-standard protocol.)